According to Genscript Biotech 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.90449. At the end of 2021 the company had a P/S ratio of 18.2.
Year | P/S ratio | Change |
---|---|---|
2021 | 18.2 | 151.06% |
2020 | 7.25 | -53.6% |
2019 | 15.6 | 45.77% |
2018 | 10.7 | -62.87% |
2017 | 28.9 | 315.63% |
2016 | 6.94 | 120.88% |
2015 | 3.14 |